Investigating the T regulatory cells and Sirtuin-I serum level in immunotherapy treated house dust mite allergic asthma patients

References

• Ajduk J, Marinic I, Aberle N, Rabatic S, GaGro A. Effect of house dust mite immunotherapy on transforming growth factor beta1- producing T cells in asthmatic children. Ann Allergy Asthma Immunol. 2008;100(4):314–322. doi:10.1016/S1081-1206(10)60592-3.
   PubMed Web of Science ®Google Scholar
• Akdis M. Healthy immune response to allergens: t regulatory cells and more. Curr Opin Immunol. 2006;18(6):738–744. doi:10.1016/j.coi.2006.06.003.
   PubMed Web of Science ®Google Scholar
• Arlian LG, Morgan MS, Neal JS. Dust mite allergens: ecology and distribution. Curr Allergy Asthma Rep. 2002;2(5):401–411. doi:10.1007/s11882-002-0074-2.
   PubMedGoogle Scholar
• Aron JL, Akbari O. Regulatory T cells and type 2 innate lymphoid cell-dependent asthma. Allergy. 2017;72(8):1148–1155. doi:10.1111/all.13139.
   PubMed Web of Science ®Google Scholar
• Bacher P, Alexander Scheffold A. The effect of regulatory T cells on tolerance to airborne allergens and allergen immunotherapy. J Allergy Clin Immunol. 2018;142(6):1697–1709. doi:10.1016/j.jaci.2018.10.016.
   PubMed Web of Science ®Google Scholar
• Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol. 2007;120(3):707–713. doi:10.1016/j.jaci.2007.06.013.
   PubMed Web of Science ®Google Scholar
• Chabra R, Gupta M. 2022. Allergic and environmental-induced asthma. Treasure Island (FL): StatPearls.
   Google Scholar
• Chadha S, Wang L, Hancock WW, Beier UH. Sirtuin-1 in immunotherapy: a Janus-headed target. J Leukoc Biol. 2019;106(2):337–343. doi: 10.1002/JLB.2RU1118-422R.
   Web of Science ®Google Scholar
• Foresi A, Paggiaro P. Inhaled corticosteroids and leukotriene modifiers in the acute treatment of asthma exacerbations. Curr Opin Pulm Med. 2003;9(1):52–56. doi:10.1097/00063198-200301000-00009.
   PubMed Web of Science ®Google Scholar
• Akdis M, Akdis C. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol. 2007;119(4):780–791. doi:10.1016/j.jaci.2007.01.022.
   PubMed Web of Science ®Google Scholar
• Huang M, Dong J. Critical roles of balanced T helper 9 cells and regulatory T cells in allergic airway inflammation and tumor immunity. J Immunol Res. 2021;2021:8816055–8816020. doi:10.1155/2021/8816055.
   PubMed Web of Science ®Google Scholar
• Roy SR, Sigmon JR, Olivier J, Moffitt JE, Brown DA, Marshall GD. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol. 2007;99(1):82–86. doi:10.1016/S1081-1206(10)60626-6.
   PubMed Web of Science ®Google Scholar
• Colley T, Mercado N, Kunori Y, Brightling C, Bhavsar PK, Barnes PJ, Ito K. Defective sirtuin-1 increases IL-4 expression through acetylation of GATA-3 in patients with severe asthma. J Allergy Clin Immunol. 2016;137(5):1595–1597.e7. doi:10.1016/j.jaci.2015.10.013.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance is maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). The breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155(3):1151–1164.
   PubMed Web of Science ®Google Scholar
• Luo Z-X, Liu E-M, Deng B, Li X, Chen K-H, Wang L-J, Huang Y, Fu Z. Role of Foxp3 expression and CD4 + CD25+ regulatory T cells on the pathogenesis of childhood asthma. Zhonghua Er Ke Za Zhi. 2006;44(4):267–271.
   PubMedGoogle Scholar
• Kussebi F, Karamloo F, Akdis M, Blaser K, Akdis C. Advances in immunological treatment of allergy. CMCAIAA. 2003;2(4):297–308. doi:10.2174/1568014033483699.
   Google Scholar
• Bagnasco D, Caminati M, Ferrando M, Aloè T, Testino E, Canonica GW, Passalacqua G. Anti-IL-5 and IL-5Ra: efficacy and safety of new therapeutic strategies in severe uncontrolled asthma. Biomed Res Int. 2018;2018:5698212–5698218. doi:10.1155/2018/5698212.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li D, Ma G, Li W, Wu J, Lai T, Huang D, Zhao X, Lv Q, Chen M, et al. Increases in peripheral SIRT1: A new biological characteristic of asthma. Respirology. 2015;20(7):1066–1072. doi:10.1111/resp.12558.
   PubMed Web of Science ®Google Scholar
• Larché M. Regulatory T cells in allergy and asthma. Chest. 2007;132(3):1007–1014. doi:10.1378/chest.06-2434.
   PubMed Web of Science ®Google Scholar
• Boonpiyathad T, Sözener ZC, Akdis M, Akdis CA. The role of Treg cell subsets in allergic disease. Asian Pac J Allergy Immunol. 2020;38(3):139–149. doi:10.12932/AP-030220-0754.
   PubMed Web of Science ®Google Scholar
• Zhu X, Chen Q, Liu Z, Luo D, Li L, Zhong Y. Low expression and hypermethylation of FOXP3 in regulatory T cells are associated with asthma in children. Exp Therap Med. 2020;19:2045–2052.
   PubMed Web of Science ®Google Scholar
• Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, Nelson M, Weber R, Bernstein DI, Blessing-Moore J, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(1):S1–S55. doi:10.1016/j.jaci.2010.09.034.
   PubMed Web of Science ®Google Scholar
• Dijk BV, Svedsater H, Heddini A, Nelsen L, Balradj JS, Alleman C. Relationship between the Asthma Control Test (ACT) and other outcomes: a targeted literature review. BMC Pulm Med. 2020;20(1):79. doi:10.1186/s12890-020-1090-5.
   PubMed Web of Science ®Google Scholar
• GINA. National Institutes of Health. Global initiative for asthma. Global strategy for Asthma Management and Prevention Revision. 2020. Available from: https://ginasthma.org/.
   Google Scholar
• F de B, Gherasim A, Casale TB, Doyen V, Bernstein D. Which patients with asthma are most likely to benefit from allergen immunotherapy? J Allergy Clin Immunol. 2022;149(3):833–843. doi:10.1016/j.jaci.2022.01.011.
   PubMed Web of Science ®Google Scholar
• Tsabouri S, Mavroudi A, Feketea G, Guibas GV. Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children. Front Pediatr. 2017;5:82. Erratum in: doi:10.3389/fped.2017.00082.
   PubMed Web of Science ®Google Scholar
• Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, Duan S, Eiwegger T, Eljaszewicz A, Ferstl R, et al. Interleukins (From IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2016;138(4):984–1010. doi:10.1016/j.jaci.2016.06.033.
   PubMed Web of Science ®Google Scholar
• Lin Y-L, Shieh C-C, Wang J-Y. The functional insufficiency of human CD4 + CD25 high T-regulatory cells in allergic asthma is subjected to TNF-α modulation. Allergy. 2008;63(1):67–74. doi:10.1111/j.1398-9995.2007.01526.x.
   PubMed Web of Science ®Google Scholar
• Ray A, Khare A, Krishnamoorthy N, Qi Z, Ray P. Regulatory T cells in many flavors control asthma. Mucosal Immunol. 2010;3(3):216–229. doi:10.1038/mi.2010.4.
   PubMed Web of Science ®Google Scholar
• Lu Y, Li V, Zhou W, Ding B, Yu Q. Regulatory T cells regulate the distribution of natural killer T cells through CD39 signal transduction in asthma. Human Cell. 2019;32(2):141–149. doi:10.1007/s13577-018-00226-0.
   PubMed Web of Science ®Google Scholar
• Mahesh PA, Kushalappa PA, Holla AD, Vedanthan PK. Urticaria., House dust mite sensitivity is a factor in chronic. Indian J Dermatol Venereol Leprol. 2005;71(2):99–101. doi:10.4103/0378-6323.13993.
   PubMedGoogle Scholar
• Mamessier E, Nieves A, Lorec A-M, Dupuy P, Pinot D, Pinet C, Vervloet D, Magnan A. T cell activation during exacerbations: a longitudinal study in refractory asthma. Allergy. 2008;63(9):1202–1210. doi:10.1111/j.1398-9995.2008.01687.x.
   PubMed Web of Science ®Google Scholar
• Marques CR, Costa RS, Costa GdO, Silva T d, Teixeira TO, Andrade E d, Galvão AA, Carneiro VL, Figueiredo CA. Genetic and epigenetic studies of FOXP3 in asthma and allergy. Asthma Res Pract. 2015;1(1):10. doi:10.1186/s40733-015-0012-4.
   PubMedGoogle Scholar
• Noh SJ, Baek HA, Park HS, Jang KY, Moon WS, Kang MJ, Lee DG, Kim MH, Lee JH, Chung MJ. Expression of SIRT1 and cortactin is associated with the progression of non-small cell lung cancer. Pathol Res Pract. 2013;209(6):365–370. doi:10.1016/j.prp.2013.03.011.
   PubMed Web of Science ®Google Scholar
• Oliveira CD, Binotti RS, Oppermann Muniz JR, Santos JD, Prado AD, Pinho AD. Comparison of house dust mites found on different mattress surfaces. Ann Allergy Asthma Immunol. 2003;91(6):559–562. doi:10.1016/S1081-1206(10)61534-7.
   PubMed Web of Science ®Google Scholar
• Ozdemir C, Akdis M, Akdis CA. Nature of regulatory T cells in the context of allergic disease. Allergy Asthma Clin Immunol. 2008;4(3):106–110. doi:10.1186/1710-1492-4-3-106.
   PubMedGoogle Scholar
• Ozdemir C, Yazi D, Gocmen I, Yesil O, Aydogan M, Semic-Jusufagic A, Bahceciler NN, Barlan IB. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma. Pediatr Allergy Immunol. 2007;18(6):508–515. doi:10.1111/j.1399-3038.2007.00549.x.
   PubMed Web of Science ®Google Scholar
• Provoost S, Maes T, Durme YV, Gevaert P, Bachert C, Schmidt-Weber CB, Brusselle GG, Joos GF, Tournoy KG. Decreased FOXP3 protein expression in patients with asthma. Allergy. 2009;64(10):1539–1546. doi:10.1111/j.1398-9995.2009.02056.x.
   PubMed Web of Science ®Google Scholar
• Raedler D, Ballenberger N, Klucker E, Böck A, Otto R, Prazeres da Costa O, Holst O, Illig T, Buch T, Mutius E v, et al. Identification of novel immune phenotypes for allergic and nonallergic childhood asthma. J Allergy Clin Immunol. 2015;135(1):81–91. doi:10.1016/j.jaci.2014.07.046.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen L, Xiong F, Zhang S, Huang K, Zhang Z, Wang C-Y. Autophagy in regulatory T cells: A double-edged sword in disease settings. Mol Immunol. 2019;109:43–50. doi:10.1016/j.molimm.2019.02.004.
   PubMed Web of Science ®Google Scholar
• Senti G, Prinz Vavricka BM, Erdmann I, Diaz MI, Markus R, Mccormack SJ, Simard JJ, Wü B, Crameri R, Graf N, et al. Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. 2008;105(46):17908–17912. doi: 10.1073/pnas.0803725105.
   Google Scholar
• Shamji MH, Layhadi JA, Achkova D, Kouser L, Perera-Webb A, Couto-Francisco NC, Parkin RV, Matsuoka T, Scadding G, Ashton-Rickardt PG, et al. Role of IL-35 in sublingual allergen immunotherapy. J Allergy Clin Immunol. 2019;143(3):1131–1142.e4. doi:10.1016/j.jaci.2018.06.041.
   PubMed Web of Science ®Google Scholar
• Shin JW, Sue JH, Song TW, Kim KW, Kim ES, Sohn MH, Kim KE. Atopy and house dust mite sensitization as risk factors for asthma in children. Yonsei Med J. 2005;46(5):629–634. doi:10.3349/ymj.2005.46.5.629.
   PubMed Web of Science ®Google Scholar
• K S. The allergenic acarofauna of house dust from dwellings, hospitals, libraries, and institutes in Upper Silesia (Poland). Ann Agric Environ Med. 1998;5:73–85.
   PubMed Web of Science ®Google Scholar
• Smyth LJ, Eustace A, Kolsum U, Blaikely J, Singh D. Increased airway T regulatory cells in asthmatic subjects. Chest. 2010;138(4):905–912. doi:10.1378/chest.09-3079.
   PubMed Web of Science ®Google Scholar
• Terada T, Kawata R, KRyo Alternatives to subcutaneous immunotherapy for allergic rhinitis. Allergies. 2022;2(1):23–32. doi:10.3390/allergies2010003.
   Google Scholar
• Thomas WR, Smith WA, Hales BJ. The allergenic specificities of the house dust mite. Chang Gung Med J. 2004;27(8):563–569.
   PubMedGoogle Scholar
• Thunberg S, Gafvelin G, Nord M, Grönneberg R, Grunewald J, Eklund A, van Hage M. Allergen provocation increases TH2-cytokines and FOXP3 expression in the asthmatic lung. Allergy. 2010;65(3):311–318. doi:10.1111/j.1398-9995.2009.02218.x.
   PubMed Web of Science ®Google Scholar
• Tsilogianni Z, Baker JR, Papaporfyriou A. Sirtuin 1: endocan and sestrin 2 in different biological samples in patients with asthma. Does severity make the difference? J. Clin Med. 2020;9(2):473. doi: 10.3390/jcm9020473.
   PubMedGoogle Scholar
• Wang L, Kumar S, Dahiya S, Wang F, Wu J, Newick K, Han R, Samanta A, Beier UH, Akimova T, et al. Ubiquitin-specific Protease-7 inhibition impairs Tip60-dependent Foxp3+ T-regulatory cell function and promotes antitumor immunity. EBioMedicine. 2016;13:99–112. doi:10.1016/j.ebiom.2016.10.018.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Lockey R, Malling H. Allergen immu­notherapy: therapeutic vaccines for allergic diseases. J Allergy Clin Immunol. 1998;102(4 Pt 1):558–562. doi:10.1016/s0091-6749(98)70271-4.
   PubMed Web of Science ®Google Scholar
• Xian M, Feng M, Dong Y, Wei N, Su Q, Li J. Changes in CD4 + CD25 + FoxP3+ regulatory T cells and serum cytokines in sublingual and subcutaneous immunotherapy in allergic rhinitis with or without asthma. Int Arch Allergy Immunol. 2020;181(1):71–80. doi:10.1159/000503143.
   PubMed Web of Science ®Google Scholar
• Yang K, Dong W. SIRT1-related signaling pathways and their association with bronchopulmonary dysplasia. Front Med (Lausanne). 2021;8:595634. doi:10.3389/fmed.2021.595634.
   PubMed Web of Science ®Google Scholar
• Yoshizaki T, Schenk S, Imamura T, Babendure J, Sonoda N, Bae EJ, Oh DY, Lu M, Milne JC, Westphal C, et al. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab. 2010;298(3):E419–E428. doi:10.1152/ajpendo.00417.2009.
   PubMed Web of Science ®Google Scholar
• Yu J, Liu X, Li Y, Meng S, Wu F, Yan B, Xue Y, Ma T, Yang, J, Liu. Maternal exposure to farming environments protects offspring against allergic diseases by modulating the neonatal TLR-Tregs-Th axis. Clin Transl Allergy. 2018;17:34.
   Google Scholar
• Zhang H, Sun Y, Rong W, Fan L, Cai Y, Qu Q, Gao Y, Zhao H. miR-221 participates in the airway epithelial cell injury in asthma via targeting SIRT1. Exp Lung Res. 2018;44(6):272–279. doi:10.1080/01902148.2018.1533051.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zou Y, Chen L, Xu Q, Wang Y, Xie M, Liu X, Zhao J, Wang CY. Regulatory T cells, a viable target against airway allergic inflammatory responses in asthma. Front Immunol. 2022;13:902318. doi:10.3389/fimmu.2022.902318.
   PubMed Web of Science ®Google Scholar
• Frew AJ. How does sublingual immunotherapy work? J Allergy Clin Immunol. 2007;120(3):533–536. doi:10.1016/j.jaci.2007.08.003.
   PubMed Web of Science ®Google Scholar
• Gex G, Nendaz M, Janssens JP. Leukotriene-modifiers in asthma treatment. Rev Med Suisse. 2006;2(77):1997.
   PubMedGoogle Scholar
• Giannetti A, Ricci G, Procaccianti M, Santoro A, Caffarelli C. Safety, efficacy, and preventive role of subcutaneous and sublingual allergen immunotherapy for the treatment of pediatric asthma. J Asthma Allergy. 2020;13:575–587. doi:10.2147/JAA.S234280.
   PubMed Web of Science ®Google Scholar